Stock listing
0ET Stock Price, News, Filings & Events — Esperion Therapeutics, Inc.
Selected listing: 0ET · TRADEGATE · EUR · DE
This page tracks Esperion Therapeutics, Inc.'s 0ET:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 0ET:TRADEGATE. 0ET:TRADEGATE is the stock-level entry point for investors researching Esperion Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Esperion Therapeutics, Inc. is a publicly traded company on the American market, with a market capitalization of approximately $819.5 million. The company focuses on developing and commercializing innovative therapies for patients with cardiovascular diseases. Esperion is dedicated to addressing unmet medical needs through its research and product offerings.
- Ticker
- 0ET:TRADEGATE
- Asset type
- Stock
- Market cap
- $819.5M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TRADEGATE
- Currency
- EUR
Esperion Therapeutics, Inc. 0ET:TRADEGATE stock context
This page tracks Esperion Therapeutics, Inc.'s 0ET:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 0ET:TRADEGATE. 0ET:TRADEGATE is the stock-level entry point for investors researching Esperion Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Esperion Therapeutics, Inc. is a publicly traded company on the American market, with a market capitalization of approximately $819.5 million. The company focuses on developing and commercializing innovative therapies for patients with cardiovascular diseases. Esperion is dedicated to addressing unmet medical needs through its research and product offerings.
Latest news from Esperion Therapeutics, Inc.
Esperion Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Esperion Ther...
June 17, 2026
Esperion Presents New Data from CLEAR Outcomes and the CLEAR PATH Phase 2 Pediatric Study at the European Atherosclerosis Society Congres...
May 26, 2026
Esperion Announces Two New Analyses Supporting Bempedoic Acid to Reduce LDL-C Levels to be Presented at the European Atherosclerosis Soci...
May 13, 2026
Esperion to be Acquired by ARCHIMED
May 1, 2026
Esperion to Report First Quarter 2026 Financial Results on May 7
April 23, 2026
Esperion Therapeutics, Inc. earnings calls
Esperion Therapeutics, Inc. (ESPR) Q4 2025 Earnings Call
March 10, 2026 · Replay with transcript and chapters
Esperion Therapeutics, Inc. (ESPR) Q3 2025 Earnings Call
November 6, 2025 · Replay with transcript and chapters
Esperion Therapeutics, Inc. (ESPR) Q2 2025 Earnings Call
August 5, 2025 · Replay with transcript and chapters
Esperion Therapeutics, Inc. (ESPR) Q1 2025 Earnings Call
May 6, 2025 · Replay with transcript and chapters
Esperion Therapeutics, Inc. (ESPR) Q4 2024 Earnings Call
March 4, 2025 · Replay with transcript and chapters
Esperion Therapeutics, Inc. (ESPR) Q3 2024 Earnings Call
November 7, 2024 · Replay with transcript and chapters
Research Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for 0ET:TRADEGATE.
Esperion Therapeutics, Inc. company profile
View the public company page for Esperion Therapeutics, Inc. on 6ix.
Esperion Therapeutics, Inc. news
Read company news and market updates connected to Esperion Therapeutics, Inc..
Esperion Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Esperion Therapeutics, Inc..
Alternate listings
ESPR:NASDAQ
US · USD
Alternate listing for Esperion Therapeutics, Inc.; the primary context on this page is 0ET:TRADEGATE.
0IIM:LSE
GB · USD
Alternate listing for Esperion Therapeutics, Inc.; the primary context on this page is 0ET:TRADEGATE.
0ET:GETTEX
DE · EUR
Alternate listing for Esperion Therapeutics, Inc.; the primary context on this page is 0ET:TRADEGATE.
0ET:SWB
DE · EUR
Alternate listing for Esperion Therapeutics, Inc.; the primary context on this page is 0ET:TRADEGATE.
ESPR:BOATS
US · USD
Alternate listing for Esperion Therapeutics, Inc.; the primary context on this page is 0ET:TRADEGATE.
A1W1SJ:LSX
DE · EUR
Alternate listing for Esperion Therapeutics, Inc.; the primary context on this page is 0ET:TRADEGATE.
A1W1SJ:LS
DE · EUR
Alternate listing for Esperion Therapeutics, Inc.; the primary context on this page is 0ET:TRADEGATE.
0ET:BX
CH · CHF
Alternate listing for Esperion Therapeutics, Inc.; the primary context on this page is 0ET:TRADEGATE.
0ET:FWB
DE · EUR
Alternate listing for Esperion Therapeutics, Inc.; the primary context on this page is 0ET:TRADEGATE.
0ET:DUS
DE · EUR
Alternate listing for Esperion Therapeutics, Inc.; the primary context on this page is 0ET:TRADEGATE.
0ET:MUN
DE · EUR
Alternate listing for Esperion Therapeutics, Inc.; the primary context on this page is 0ET:TRADEGATE.